Year archive

Shanghai Bao Pharmaceuticals Co., Ltd. — 2025 filings

All 15 regulatory filings released by Shanghai Bao Pharmaceuticals Co., Ltd. (2659) in 2025, sourced directly from the official regulator.

15 Filings

2025 Period

2025 filings (15)

Filing	Released	Lang
INSIDE INFORMATION - PROPOSED IMPLEMENTATION OF H SHARE FULL CIRCULATION PROGRAM BY THE COMPANY Share Issue/Capital Change	2025-12-30	English
ANNOUNCEMENT OF FINAL OFFER PRICE AND ALLOTMENT RESULTS Regulatory Filings	2025-12-09	English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS Board/Management Information	2025-12-08	English
Terms of Reference for the Nomination Committee of the Board of Directors Governance Information	2025-12-08	English
Terms of reference for the Remuneration Committee of the Board of Directors Governance Information	2025-12-08	English
Terms of Reference for the Audit Committee of the Board of Directors Governance Information	2025-12-08	English
Articles of Association Governance Information	2025-12-08	English
Documents on Display Regulatory Filings	2025-12-01	English
GLOBAL OFFERING Share Issue/Capital Change	2025-12-01	English
GLOBAL OFFERING Capital/Financing Update	2025-12-01	English
PHIP (1st submission) Regulatory Filings	2025-11-26	English
PHIP (1st submission) Regulatory Filings	2025-11-26	English
OC Announcement - Appointment Share Issue/Capital Change	2025-08-21	English
Application Proof (1st submission) Regulatory Filings	2025-08-21	English
Application Proof (1st submission) Share Issue/Capital Change	2025-08-21	English